Compare Laekna, Inc. with Similar Stocks
Dashboard
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 388.70% and Operating profit at 9.67% over the last 5 years
- The company is Net-Debt Free
2
Risky -
3
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-43.27%
0%
-43.27%
6 Months
-45.66%
0%
-45.66%
1 Year
10.68%
0%
10.68%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Laekna, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
388.70%
EBIT Growth (5y)
9.67%
EBIT to Interest (avg)
-111.74
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.87
Sales to Capital Employed (avg)
0.08
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.30
EV to EBIT
-5.97
EV to EBITDA
-6.09
EV to Capital Employed
41.88
EV to Sales
15.09
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-702.14%
ROE (Latest)
-18.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
115.70
0.00
Operating Profit (PBDIT) excl Other Income
-286.90
-307.90
6.82%
Interest
4.20
3.30
27.27%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-248.70
-275.70
9.79%
Operating Profit Margin (Excl OI)
-2,529.60%
0.00%
-252.96%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 9.79% vs 32.34% in Dec 2024
About Laekna, Inc. 
Laekna, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






